Trials / Unknown
UnknownNCT05450627
Registry of Pancreatic Exocrine Insufficiency.
Development of a Registry of Patients With Pancreatic Exocrine Insufficiency of Different Etiologies
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Hospital Clinico Universitario de Santiago · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A prospective, cross-sectional, observational study has been designed with the aim of the study is to evaluate the diagnosis and management of patients with pancreatic exocrine insufficiency secondary to different pancreatic diseases and conditions in clinical practice. A registry has been develop to include patients older than 18 years diagnosed with pancreatic exocrine insufficiency, sho are willing to participate in the study and sign the informed consent. Registry includes demographics, toxic habits,pharmacological therapies, underlying disease that causes pancreatic exocrine insufficiency.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pancreatic Enzyme | Registry of pancreatic enzyme therapy prescribed to included patients |
Timeline
- Start date
- 2021-06-01
- Primary completion
- 2023-06-30
- Completion
- 2023-12-31
- First posted
- 2022-07-11
- Last updated
- 2022-07-11
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT05450627. Inclusion in this directory is not an endorsement.